2097132-93-7
2097132-93-7
Chemical Structure
trans-Pralsetinib
Synonym(s): trans-BLU-667
- CAS. Nr.: 2097132-93-7
- Formula:C27H32FN9O2
- Molecular Weight:533.60
IUPAC Name: (1r,4S)-N-((S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)cyclohexane-1-carboxamide
InChIKey: GBLBJPZSROAGMF-BATDWUPUSA-N
SMILES: O=C([C@]1(OC)CC[C@H](C2=NC(NC3=NNC(C)=C3)=CC(C)=N2)CC1)N[C@H](C4=CC=C(N5N=CC(F)=C5)N=C4)C
Biological Activity: trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
trans-Pralsetinib | 98.06% | trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
trans-Pralsetinib (Standard) | ≥98% | trans-Pralsetinib (Standard) is the analytical standard of trans-Pralsetinib. This product is intended for research and analytical applications. trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection (RET) inhibitor extracted from patent US20170121312A1, Compound Example 129. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
